efficacy and safety of lurbinectedin in elderly patients with relapsed sclc
Published 1 year ago • 355 plays • Length 0:50Download video MP4
Download video MP3
Similar videos
-
1:52
lurbinectedin in combination with pembrolizumab in relapsed sclc
-
0:52
luper: lurbinectedin in combination with pembrolizumab in relapsed sclc
-
2:01
palliative radiotherapy with lurbinectedin in patients with extensive stage sclc
-
7:14
safety and efficacy of single agent rovalpituzumab tesirine in small cell lung cancer (sclc)
-
4:18
lurbinectedin’s role in managing sclc
-
1:00
lurbinectedin efficacy & safety highlights
-
2:50
dr. farago on effectiveness of single-agent lurbinectedin in sclc
-
0:39
future potential and challenges of adapt-001: evaluating efficacy and exploring new cancer types
-
2:15
no os benefit with lurbinectedin/doxorubicin in sclc - medpage today
-
2:53
the current treatment landscape for sclc
-
1:28
dr. forster on recent data with lurbinectedin in sclc
-
4:36
efficacy and safety of checkpoint inhibitors in lung cancer
-
7:39
data on fda approved therapy for relapsed/refractory sclc
-
0:38
advancing targeted therapies for sclc
-
2:03
chemoradiation and immunotherapy for patients with small cell lung cancer
-
2:01
findings from atlantis: lurbinectedin/doxorubicin vs topotecan or cav in sclc
-
5:24
asco 2019 lung cancer roundtable - lurbinectedin - how promising is this for relapsed sclc
-
0:48
immunotherapy for patients with small-cell lung cancer
-
17:10
sclc: therapeutic progress or mirage?